UNCY earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -2.72. Updated 2026-07-23.
Unicycive Therapeutics (UNCY) Research Hub
Unicycive Therapeutics (UNCY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.58 USD (-7.97%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.72, market cap 0.12B. This hub links to the full technical, earnings and options research available for UNCY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.58 USD (-7.97%) |
| 52-week range | 3.35 USD – 8.43 USD |
| Trend regime | Range |
| 14-day RSI | 32.8 (Bearish) |
| Trailing P/E | -2.72 |
| Market cap | 0.12B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for UNCY
Covered Call on UNCY: how it works, illustrative setup around the real 3.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on UNCY: how it works, illustrative setup around the real 3.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on UNCY: how it works, illustrative setup around the real 3.58 USD price, max profit/loss, breakeven and when to use it. Educational.
UNCY technical analysis: range, last 3.58 USD, RSI 32.8, 52w range 3.35 USD–8.43 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is UNCY in?
Unicycive Therapeutics (UNCY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is UNCY in an uptrend or downtrend?
As of 2026-10-26, UNCY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is UNCY's trailing P/E ratio?
UNCY's trailing P/E is -2.72, with a market cap of 0.12B. See the earnings research page for full valuation detail.
When does UNCY next report earnings?
UNCY is next scheduled to report earnings on 2026-08-13.